4-Pyridinethiol, 3-ethyl- | 102000-65-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 4-Pyridinethiol, 3-ethyl-
• 英文别名: 3-ethyl-1H-pyridine-4-thione
• CAS: 102000-65-7
• 化学式: C₇H₉NS
• 分子量: 139.221
• InChiKey: VXFCSLSMTKQQSJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  44.1
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-Pyridinethiol, 3-ethyl- 在 盐酸羟胺 作用下， 生成 N-[1-(2,5-dichlorothiophen-3-yl)-2-(3-ethylpyridin-4-yl)sulfanylethylidene]hydroxylamine
  参考文献：
  名称：

  Ago-allosteric modulators of human glucagon-like peptide 2 receptor

  摘要：

  Glucagon-like peptide 2 (GLP-2) is an intestinotropic peptide that binds to GLP-2 receptor (GLP-2R), a class-B G protein-coupled receptor (GPCR). Few synthetic agonists have been reported so far for class-B GPCRs. Here, we report the first scaffold compounds of ago-allosteric modulators for human GLP-2R, derived from methyl 2-{[(2Z)-2-(2,5-dichlorothiophen-3-yl)-2-(hydroxyimino) ethyl] sulfanyl}benzoate (compound 1). (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.08.026
• 作为产物：
  描述：

  4-chloro-3-ethylpyridine 在 sodium hydrogen sulfide 作用下， 生成 4-Pyridinethiol, 3-ethyl-
  参考文献：
  名称：

  Ago-allosteric modulators of human glucagon-like peptide 2 receptor

  摘要：

  Glucagon-like peptide 2 (GLP-2) is an intestinotropic peptide that binds to GLP-2 receptor (GLP-2R), a class-B G protein-coupled receptor (GPCR). Few synthetic agonists have been reported so far for class-B GPCRs. Here, we report the first scaffold compounds of ago-allosteric modulators for human GLP-2R, derived from methyl 2-{[(2Z)-2-(2,5-dichlorothiophen-3-yl)-2-(hydroxyimino) ethyl] sulfanyl}benzoate (compound 1). (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.08.026

文献信息

• [EN] HETEROCYCLIC COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES ET LEURS UTILISATIONS
  申请人：KAYOTHERA INC

  公开号：WO2022226383A1

  公开（公告）日：2022-10-27

  Provided herein are novel heterocyclic compounds, for example, compounds having Formula I, I-P, II, II-P, III, or IV. Also provided herein are pharmaceutical compositions comprising the compounds and methods of using the same, for example, in inhibiting aldehyde dehydrogenases, retinoid pathway activation, and/or for treating various cancers, cancer metastasis, type 2 diabetes, pulmonary arterial hypertension (PAH) or neointimal hyperplasia (NIH) or as a male contraceptive.

  本文提供了新型杂环化合物，例如具有I、I-P、II、II-P、III或IV式的化合物。本文还提供了包含这些化合物的制药组合物以及使用它们的方法，例如在抑制醛脱氢酶、视黄醇途径激活和/或治疗各种癌症、癌症转移、2型糖尿病、肺动脉高压（PAH）或新内膜增生（NIH）或作为男性避孕药物。
• Ago-allosteric modulators of human glucagon-like peptide 2 receptor
  作者：Kazuto Yamazaki、Hiroki Terauchi、Daisuke Iida、Hironori Fukumoto、Shuichi Suzuki、Takaki Kagaya、Mika Aoki、Koichiro Koyama、Takashi Seiki、Kazuma Takase、Misako Watanabe、Tohru Arai、Kappei Tsukahara、Junichi Nagakawa

  DOI：10.1016/j.bmcl.2012.08.026

  日期：2012.10

  Glucagon-like peptide 2 (GLP-2) is an intestinotropic peptide that binds to GLP-2 receptor (GLP-2R), a class-B G protein-coupled receptor (GPCR). Few synthetic agonists have been reported so far for class-B GPCRs. Here, we report the first scaffold compounds of ago-allosteric modulators for human GLP-2R, derived from methyl 2-[(2Z)-2-(2,5-dichlorothiophen-3-yl)-2-(hydroxyimino) ethyl] sulfanyl}benzoate (compound 1). (C) 2012 Elsevier Ltd. All rights reserved.